Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers
AssigneeAlgipharma AS
InventorsAristides Tagalakis, Stephen Hart, Arne Dessen, Are Kristiansen, Philip D. Rye
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlgipharma AS
InventorsAristides Tagalakis, Stephen Hart, Arne Dessen, Are Kristiansen, Philip D. Rye
Estimating the term…
A micro/nanoparticle formed of self-assembling micro/nanoparticle forming components, wherein at least one self-assembling micro/nanoparticle forming component is a cationic micro/nanoparticle forming component and at least one is an alginate oligomer which has at least 70% mannuronate residues, and the micro/nanoparticle further includes a molecule of interest, optionally wherein the molecule of interest is covalently bound to one or more of the self-assembling micro/nanoparticle forming components. Also disclosed are methods for translocating a cationic micro/nanoparticle across a mucus layer including contacting the mucus layer with at least one alginate oligomer, the alginate oligomer having at least 70% mannuronate residues, together with the cationic micro/nanoparticle; or contacting the cationic micro/nanoparticle with an alginate oligomer having at least 70% mannuronate residues thereby forming a micro/nanoparticle carrying the alginate oligomer, and contacting the mucus layer with the micro/nanoparticle.
A micro/nanoparticle formed of self-assembling micro/nanoparticle forming components, wherein
A method for translocating a cationic micro/nanoparticle across a mucus layer said method comprising
A method for translocating a molecule of interest across a mucus layer said method comprising contacting the mucus layer with a micro/nanoparticle which is
Dependencies are inferred from the claim text.